The nephrologists market is expected to be worth roughly $10,818.3 million in 2021, with a compound annual growth rate (CAGR) of 3.7% from 2016. The market is predicted to increase at a 7.3% annual pace from $10,818.3 million in 2021 to $15,358.7 million in 2026. The market is then predicted to increase at an 8.0% CAGR from 2026 to 2031, reaching $22,558.2 million.

Increased kidney diseases, an ageing population pool, an increase in diabetes prevalence, an increase in hypertension cases, public health insurance reforms, increased pharmaceutical R&D expenditure, increased healthcare expenditure, and an increase in the number of healthcare facilities all contributed to historical growth.

The nephrologists market is divided into three categories: owner-solo practise, owner-group practise, and full-time employment. The full-time employed market accounted for 60.0% of the total in 2021, making it the largest component of the nephrologists market classified by practise. Going forward, the full-time employed market is predicted to be the fastest expanding category in the nephrologists market by practise, increasing at a CAGR of 7.4% between 2021 and 2026.